Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection

Otolaryngol Head Neck Surg. 2014 Apr;150(4):610-7. doi: 10.1177/0194599814520686. Epub 2014 Jan 28.

Abstract

Objective: Evaluate characteristics and risk factors for patients with advanced cutaneous squamous cell carcinoma (cSCC).

Study design: Retrospective case series.

Setting: Tertiary care center.

Patients and methods: Chart review of patients with cSCC undergoing a parotidectomy (2003-2012).

Results: Of 218 patients identified, 49% presented with a new primary lesion (n = 107) and 51% with a recurrence (n = 111). Parotid lymph nodes were positive in 52% of patients; 81% had a concurrent neck dissection, and 28% had cervical lymph node metastases. In 18% of patients, both parotid and cervical nodes were positive, while 44% were both parotid and cervical node negative; 33% had positive parotid and negative cervical nodes, and only 5% had negative parotid and positive cervical nodes. The overall 2- and 5-year survival rates were 0.71 and 0.58. Overall 5-year survival was lower for patients presenting with recurrent (0.49) versus new primary disease (0.69; P = .04). In addition, decreased overall 5-year survival rates were associated with cervical lymph node involvement (0.47 vs. 0.62; P = .01). There was no difference in overall survival when stratified by parotid lymph node involvement (P = .85), margin status (P = .67), perineural invasion (P = .42), facial nerve sacrifice (P = .92), or type of parotid operation performed (P = .51).

Conclusions: In this study, cervical, but not parotid, lymph node involvement was associated with poor outcomes in patients with advanced cSCC requiring a parotidectomy. In patients without evidence of cervical or parotid lymph node involvement, a neck dissection may be spared, given there is a 5% chance of occult disease.

Keywords: cutaneous squamous cell carcinoma; outcomes; parotid; prognostic indicators.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biopsy, Needle
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / secondary*
  • Carcinoma, Squamous Cell / surgery
  • Cohort Studies
  • Disease-Free Survival
  • Female
  • Head and Neck Neoplasms / mortality
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / surgery
  • Humans
  • Immunohistochemistry
  • Lymph Nodes / pathology*
  • Lymph Nodes / surgery
  • Male
  • Middle Aged
  • Neoplasm Invasiveness / pathology
  • Neoplasm Recurrence, Local / mortality
  • Neoplasm Recurrence, Local / pathology*
  • Neoplasm Recurrence, Local / surgery
  • Neoplasm Staging
  • Parotid Neoplasms / mortality
  • Parotid Neoplasms / secondary*
  • Parotid Neoplasms / surgery
  • Patient Selection
  • Prognosis
  • Retrospective Studies
  • Risk Assessment
  • Skin Neoplasms / mortality
  • Skin Neoplasms / pathology*
  • Skin Neoplasms / surgery
  • Survival Analysis
  • Tertiary Care Centers
  • Treatment Outcome